|
1. Bennani-Baiti N, Davis MP. Cytokines and cancer anorexia cachexia syndrome. Am J Hosp Palliat Care. 2008 Oct-Nov; 25(5): 407-11. DOI: 10.1177/1049909108315518 2. Bossola M, Marzetti E, Rosa F, Pacelli F. Skeletal muscle regeneration in cancer cachexia. Clin Exp Pharmacol Physiol. 2016 May; 43(5): 522-27. DOI: 10.1111/1440-1681.12559 3. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May; 12(5): 489-95. DOI: 10.1016/S1470-2045(10)70218-7 4. Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015 Apr; 7(4): 17-29. DOI: 10.4251/wjgo.v7.i4.17 5. Fu X, Wang H, Hu P. Stem cell activation in skeletal muscle regeneration. Cell Mol Life Sci. 2015 May; 72(9): 1663-77. DOI: 10.1007/s00018-014-1819-5 6. Karalaki M, Fili S, Philippou A, Koutsilieris M. Muscle regeneration: cellular and molecular events. In Vivo. 2009 Sep-Oct; 23(5): 779-96. 7. Dumont NA, Bentzinger CF, Sincennes MC, Rudnicki MA. Satellite cells and skeletal muscle regeneration. Compr Physiol. 2011 Jul; 5(3): 1027-59. DOI: 10.1002/cphy.c140068 8. Pugh JK, Faulkner SH, Turner MC, Nimmo MA. Satellite cell response to concurrent resistance exercise and high-intensity interval training in sedentary, overweight/obese, middle-aged individuals. Eur J Appl Physiol. 2018 Feb; 118(2): 225-38. DOI: 10.1007/s00421-017-3721-y 9. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell. 2000 Sep; 102(6): 777-86. 10. Cosper PF, Leinwand LA. Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer. 2012 Jun; 130(11): 2722-27. DOI: 10.1002/ijc.26298 11. Costelli P, Muscaritoli M, Bossola M, Moore-Carrasco R, Crepaldi S, Grieco G, et al. Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol. 2005 Jun; 26(6): 1663-68. 12. Saini A, Al-Shanti N, Sharples AP, Stewart CE. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol. Exp Physiol. 2012 Mar; 97(3): 400-18. DOI: 10.1113/expphysiol.2011.061028 13. Montesano A, Luzi L, Senesi P, Mazzocchi N, Terruzzi I. Resveratrol promotes myogenesis and hypertrophy in murine myoblasts. J Transl Med. 2013 Dec; 11: 310. DOI: 10.1186/1479-5876-11-310 14. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006 Dec; 127(6): 1109-22. DOI: 10.1016/j.cell.2006.11.013 15. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997 Jan; 275(5297): 218-20. DOI: 10.1126/science.275.5297.218 16. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006 Nov; 444(7117): 337-42. DOI: 10.1038/nature05354 17. Wang D, Gao Z, Zhang X. Resveratrol Induces Apoptosis in Murine Prostate Cancer Cells via Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Reactive Oxygen Species (ROS)/P53 Signaling. Med Sci Monit. 2018 Dec; 24: 8970-76. DOI: 10.12659/MSM.913290 18. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol. 1999 Feb; 126(3): 673-80. DOI: 10.1038/sj.bjp.0702357 19. Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H, et al. Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie. 2013 Aug; 68(8): 689-94. 20. Sun AY, Wang Q, Simonyi A, Sun GY. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol. 2010 Jun; 41(2-3): 375-83. DOI: 10.1007/s12035-010-8111-y 21. Busquets S, Fuster G, Ametller E, Olivan M, Figueras M, Costelli P, et al. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clin Nutr. 2007 Apr; 26(2): 239-44. DOI: 10.1016/j.clnu.2006.12.001 22. Nederveen JP, Snijders T, Joanisse S, Wavell CG, Mitchell CJ, Johnston LM, et al. Altered muscle satellite cell activation following 16 wk of resistance training in young men. Am J Physiol Regul Integr Comp Physiol. 2017 Jan; 312(1): R85-R92. DOI: 10.1152/ajpregu.00221.2016 23. Schiaffino S, Rossi AC, Smerdu V, Leinwand LA, Reggiani C. Developmental myosins: expression patterns and functional significance. Skelet Muscle. 2015 Jul; 5: 22. DOI: 10.1186/s13395-015-0046-6 24. Carraro U, Dalla Libera L, Catani C. Myosin light and heavy chains in muscle regenerating in absence of the nerve: transient appearance of the embryonic light chain. Exp Neurol. 1983 Jan; 79(1): 106-17. DOI: 10.1016/0014-4886(83)90382-5 25. Burd NA, West DW, Staples AW, Atherton PJ, Baker JM, Moore DR, et al. Low-load high volume resistance exercise stimulates muscle protein synthesis more than high-load low volume resistance exercise in young men. PLoS One. 2010 Aug; 5(8): e12033. DOI: 10.1371/journal.pone.0012033 26. Pessina P, Conti V, Pacelli F, Rosa F, Doglietto GB, Brunelli S, et al. Skeletal muscle of gastric cancer patients expresses genes involved in muscle regeneration. Oncol Rep. 2010 Sep; 24(3): 741-45. DOI: 10.3892/or_00000916 27. Shadfar S, Couch ME, McKinney KA, Weinstein LJ, Yin X, Rodríguez JE, et al. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011; 63(5): 749-62. DOI: 10.1080/01635581.2011.563032 28. Kwon I, Jang Y, Cho JY, Jang YC, Lee Y. Long-term resistance exercise-induced muscular hypertrophy is associated with autophagy modulation in rats. J Physiol Sci. 2018 May; 68(3): 269-80. DOI: 10.1007/s12576-017-0531-2 29. Bazgir B, Fathi R, Rezazadeh Valojerdi M, Mozdziak P, Asgari A. Satellite Cells Contribution to Exercise Mediated Muscle Hypertrophy and Repair. Cell J. 2017; 18(4): 473-84. DOI: 10.22074/cellj.2016.4714 30. Khamoui AV, Park BS, Kim DH, Yeh MC, Oh SL, Elam ML, et al. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia. Metabolism. 2016 May; 65(5): 685-98. DOI: 10.1016/j.metabol.2016.01.014 31. Coletti D, Aulino P, Pigna E, Barteri F, Moresi V, Annibali D, et al. Spontaneous Physical Activity Downregulates Pax7 in Cancer Cachexia. Stem Cells Int. 2016; 2016: 6729268. DOI: 10.1155/2016/6729268 32. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res. 2004 Sep; 64(18): 6725-31. DOI: 10.1158/0008-5472.CAN-04-0425 33. Ishiko O, Sumi T, Yoshida H, Hyun Y, Ogita S. Expression of apoptosis regulatory proteins in the skeletal muscle of tumor-bearing rabbits compared with diet-restricted rabbits. Int J Mol Med. 2001 Sep; 8(3): 279-83. DOI: 10.3892/ijmm.8.3.279 34. Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med. 2003; 33(2): 145-64. DOI: 10.2165/00007256-200333020-00005 35. Ballak SB, Jaspers RT, Deldicque L, Chalil S, Peters EL, de Haan A, et al. Blunted hypertrophic response in old mouse muscle is associated with a lower satellite cell density and is not alleviated by resveratrol. Exp Gerontol. 2015 Feb; 62: 23-31. DOI: 10.1016/j.exger.2014.12.020 36. Amat R, Planavila A, Chen SL, Iglesias R, Giralt M, Villarroya F. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J Biol Chem. 2009 Aug; 284(33): 21872-80. DOI: 10.1074/jbc.M109.022749 37. Kaminski J, Lançon A, Aires V, Limagne E, Tili E, Michaille JJ, Latruffe N. Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts. Biochem Pharmacol. 2012 Nov; 84(10): 1251-59. DOI: 10.1016/j.bcp.2012.08.023 38. Wang X, Pickrell AM, Zimmers TA, Moraes CT. Increase in Muscle Mitochondrial Biogenesis Does Not Prevent Muscle Loss but Increased Tumor Size in a Mouse Model of Acute Cancer-Induced Cachexia. PLoS One. 2012; 7(3): e33426. DOI: 10.1371/journal.pone.0033426 39. Sun LJ, Sun YN, Chen SJ, Liu S, Jiang GR. Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway. Biochem Biophys Res Commun. 2017 May; 487(1): 83-89. DOI: 10.1016/j.bbrc.2017.04.022 40. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schrøder HD, Olesen JL, et al. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol. 2004 Jul; 558(Pt 1): 333-40. DOI: 10.1113/jphysiol.2004.061846 41. Motallebnezhad M, Aghebati-Maleki L, Jadidi-Niaragh F, Nickho H, Samadi-Kafil H, Shamsasenjan K, et al. The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies. Tumour Biol. 2016 Sep; 37(9): 11711-21. DOI: 10.1007/s13277-016-5176-x 42. Penna F, Costamagna D, Fanzani A, Bonelli G, Baccino FM, Costelli P. Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS One. 2010 Oct; 5(10): e13604. DOI: 10.1371/journal.pone.0013604 43. Padilha CS, Borges FH, Costa Mendes da Silva LE, Frajacomo FTT, Jordao AA, Duarte JA, et al. Resistance exercise attenuates skeletal muscle oxidative stress, systemic pro-inflammatory state, and cachexia in Walker-256 tumor-bearing rats. Appl Physiol Nutr Metab. 2017 Sep; 42(9): 916-23. DOI: 10.1139/apnm-2016-0436 44. das Neves W, Alves CR, de Almeida NR, Guimarães FL, Ramires PR, Brum PC, et al. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression. Life Sci. 2016 Oct; 163: 11-22. DOI: 10.1016/j.lfs.2016.08.025 45. Ziegler CC, Rainwater L, Whelan J, McEntee MF. Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. J Nutr. 2004 Jan; 134(1): 5-10. DOI: 10.1093/jn/134.1.5 46. Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis. 2000 Aug; 21(8): 1619-22. 47. Schneider Y, Duranton B, Gossé F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer. 2001; 39(1): 102-107. DOI: 10.1207/S15327914nc391_14 48. Sengottuvelan M, Nalini N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr. 2006 Jul; 96(1): 145-53. DOI: 10.1079/bjn20061789 49. Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, et al. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer. 2009; 61(4): 544-53. DOI: 10.1080/01635580902752262 50. Alfaras I, Juan ME, Planas JM. Trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats. J Agric Food Chem. 2010 Jul; 58(13): 8104-10. DOI: 10.1021/jf100702x 51. Carbó N, Busquets S, van Royen M, Alvarez B, López-Soriano FJ, Argilés JM. TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer. 2002 Mar; 86(6): 1012-16. DOI: 10.1038/sj.bjc.6600167
|
